IMARA Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
IMARA Inc
CIK #0001672619
EDGAR Form CIK 2011 - 2026
10-K [0001672619]
10-Q [0001672619]
3 [0001672619]
4 [0001672619]
8-K [0001672619]
D [0001672619]
SC 13D [0001672619]
SC 13G [0001672619]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vestal Point Capital LP Enliven Therapeutics Inc [2026-02-17]
Polar Capital Holdings PLC Enliven Therapeutics Inc [2025-08-14]
Polar Capital Holdings PLC Enliven Therapeutics Inc [2024-11-13]
BlackRock Inc Enliven Therapeutics Inc [2024-11-08]
BlackRock Inc Enliven Therapeutics Inc [2024-10-24]
FMR LLC Enliven Therapeutics Inc [2023-05-10]
Fairmount Funds Management LLC Enliven Therapeutics Inc [2023-04-27]
Commodore Capital LP Enliven Therapeutics Inc [2023-04-24]
Venrock Healthcare Capital Partners III LP Enliven Therapeutics Inc [2023-03-13]
Citadel Advisors LLC Enliven Therapeutics Inc [2023-03-06]
View All
Form 3/4/5 Subject 2011 - 2026
Kunkel Lori Anne
Enliven Therapeutics Inc
OrbiMed Genesis GP LLC
OrbiMed Advisors LLC
OrbiMed Capital GP VII LLC
Hohl Benjamin
Collins Helen Louise
Heyman Richard A
Lyssikatos Joseph P
Patel Anish
Derynck Mika K
Ballal Rahul D
Bauer Jake
Gupta Rishi
Garland J Scott
Fair Richard A
Kintz Samuel
Phillips Andrew John
5AM Opportunities I GP LLC
5AM Partners VI LLC
5AM Opportunities I LP
Schwab Andrew J
Parmar Kush
5AM Ventures VI LP
Shah Rajeev M
Kolchinsky Peter
RA Capital Management LP
RA Capital Healthcare Fund LP
Commodore Capital LP
Gray Michael
Leonard Braden Michael
Chin Mark
Goldfischer Carl
Dalton Barbara
Mott David M
Bonita David P
Williams Laura A
Conner Edward R
Kerins Patrick J
NEA Partners 14 LP
New Enterprise Associates 14 LP
Baskett Forest
NEA 14 GP Ltd
Florence Anthony A Jr
Sandell Scott D
Sonsini Peter W
Attie Kenneth
OrbiMed Capital LLC
Nayeem Sara M
Agger Mette Kirstine
Bay City Capital Fund V Co-Investment Fund LP
Bay City Capital Fund V LP
Bay City Capital Management V LLC
Bay City Capital LLC
McArthur James G
Lundbeckfond Invest A/S
Rock Springs Capital Master Fund LP
Rock Springs Capital Management LP
Rock Springs Capital LLC
Arix Bioscience PLC
Arix Bioscience Holdings Ltd
H Lundbeck A S
Alexandria Venture Investments LLC
Pfizer Inc
Pfizer Ventures US LLC
Scheele Willem
Adams Christoph M
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Enliven Therapeutics Inc ELVN
Stock Option (right to buy) · derivative
2026-03-25 Option exercise 40,000 $0.00
Enliven Therapeutics Inc ELVN
Common Stock
2026-03-25 Option exercise 40,000 $2.48 99,200
Enliven Therapeutics Inc ELVN
Common Stock
2026-03-25 Sell 40,000 $35.10 1,404,000
Enliven Therapeutics Inc ELVN
Common Stock
2026-03-17 Option exercise 5,000 $2.48 12,400
Enliven Therapeutics Inc ELVN
Stock Option (right to buy) · derivative
2026-03-17 Option exercise 5,000 $0.00
Enliven Therapeutics Inc ELVN
Common Stock
2026-03-17 Sell 5,000 $27.76 138,800
Enliven Therapeutics Inc ELVN
Common Stock
2026-03-10 Option exercise 10,129 $2.48 25,120
Enliven Therapeutics Inc ELVN
Common Stock
2026-03-10 Sell 10,129 $30.19 305,795
Enliven Therapeutics Inc ELVN
Stock Option (right to buy) · derivative
2026-03-10 Option exercise 10,129 $0.00
Enliven Therapeutics Inc ELVN
Stock Option (right to buy) · derivative
2026-03-09 Option exercise 29,871 $0.00
Enliven Therapeutics Inc ELVN
Common Stock
2026-03-09 Option exercise 29,871 $2.48 74,080
Enliven Therapeutics Inc ELVN
Common Stock
2026-03-09 Sell 29,871 $30.02 896,727
Enliven Therapeutics Inc ELVN
Common Stock
2026-03-06 Sell 10,000 $29.58 295,800
Enliven Therapeutics Inc ELVN
Common Stock
2026-02-17 Sell 1,230 $26.18 32,201
Enliven Therapeutics Inc ELVN
Common Stock
2026-02-17 Option exercise 45,000 $2.48 111,600
Enliven Therapeutics Inc ELVN
Common Stock
2026-02-17 Sell 45,000 $26.17 1,177,650
Enliven Therapeutics Inc ELVN
Stock Option (right to buy) · derivative
2026-02-17 Option exercise 45,000 $0.00
Enliven Therapeutics Inc ELVN
Stock Option (right to buy) · derivative
2026-02-12 Grant 120,000 $0.00
Enliven Therapeutics Inc ELVN
Stock Option (right to buy) · derivative
2026-02-12 Grant 19,234 $0.00
Enliven Therapeutics Inc ELVN
Stock Option (right to buy) · derivative
2026-02-12 Grant 112,500 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com